Drug General Information |
Drug ID |
D0CB9B
|
Former ID |
DNC008469
|
Drug Name |
4-(thiazol-2-yl)thieno[3,2-d]pyrimidin-2-amine
|
Drug Type |
Small molecular drug
|
Indication |
Discovery agent
|
Investigative |
[1]
|
Structure |
|
Download
2D MOL
3D MOL
|
Formula |
C9H6N4S2
|
Canonical SMILES |
C1=CSC2=C1N=C(N=C2C3=NC=CS3)N
|
InChI |
1S/C9H6N4S2/c10-9-12-5-1-3-14-7(5)6(13-9)8-11-2-4-15-8/h1-4H,(H2,10,12,13)
|
InChIKey |
CLNBBLGSLDNSMF-UHFFFAOYSA-N
|
PubChem Compound ID |
|
Target and Pathway |
Target(s) |
Adenosine A2a receptor |
Target Info |
Inhibitor |
[1]
|
Adenosine A1 receptor |
Target Info |
Inhibitor |
[1]
|
KEGG Pathway
|
Rap1 signaling pathway
|
Calcium signaling pathway
|
cAMP signaling pathway
|
Neuroactive ligand-receptor interaction
|
Vascular smooth muscle contraction
|
Parkinson's disease
|
Alcoholismhsa04022:cGMP-PKG signaling pathway
|
Sphingolipid signaling pathway
|
Morphine addiction
|
NetPath Pathway
|
TCR Signaling Pathway
|
RANKL Signaling Pathway
|
PANTHER Pathway
|
Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway
|
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway
|
Pathway Interaction Database
|
HIF-2-alpha transcription factor network
|
PathWhiz Pathway
|
Intracellular Signalling Through Adenosine Receptor A2a and Adenosine
|
Reactome
|
NGF-independant TRKA activation
|
Adenosine P1 receptors
|
G alpha (s) signalling events
|
Surfactant metabolismR-HSA-417973:Adenosine P1 receptors
|
G alpha (i) signalling events
|
WikiPathways
|
Nucleotide GPCRs
|
Monoamine Transport
|
GPCRs, Class A Rhodopsin-like
|
NGF signalling via TRKA from the plasma membrane
|
GPCR ligand binding
|
GPCR downstream signaling
|
GPCRs, OtherWP80:Nucleotide GPCRs
|
References |
REF 1 | Bioorg Med Chem Lett. 2008 May 1;18(9):2920-3. Epub 2008 Mar 30.Antagonists of the human adenosine A2A receptor. Part 2: Design and synthesis of 4-arylthieno[3,2-d]pyrimidine derivatives. |